Infectious Encephalitis: Clinical Trials

3 trials for Infectious Encephalitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3
Phase 11Terminated 1

Follow Infectious Encephalitis: new trials by email Literature Review of Infectious Encephalitis trials Research Report on Infectious Encephalitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)
FSME-IMMUN 0.5ml Baxter - Tick-Borne Encephalitis, Encephalitis, Tick-Borne
Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)692009-09-252018-07-05
Treatment of West Nile Virus With MGAWN1
MGAWN1, Placebo - normal saline - West Nile Neuroinvasive Disease, West Nile Virus Infection
Phase 2TerminatedMacroGenics132009-05-012022-02-10
Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)
mefloquine - Progressive Multifocal Leukoencephalopathy
Phase 1 / Phase 2TerminatedBiogen372009-01-012014-07-31

Narrower conditions

Central Nervous System Diseases (1)  ·  Encephalitis (1)  ·  Encephalitis, Tick-Borne (1)  ·  Leukoencephalopathy, Progressive Multifocal (1)  ·  Meningitis (1)  ·  Tick-Borne Diseases (1)  ·  West Nile Fever (1)  ·  acute flaccid myelitis (1)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Infections (3)  ·  Central Nervous System Viral Diseases (3)  ·  Encephalitis, Viral (3)  ·  Infections (3)  ·  Nervous System Diseases (3)  ·  Neuroinflammatory Diseases (3)  ·  Virus Diseases (3)  ·  Arbovirus Infections (2)  ·  Central Nervous System Diseases (2)  ·  Encephalitis (2)  ·  Encephalitis, Arbovirus (2)  ·  Flaviviridae Infections (2)  ·  Flavivirus Infections (2)

Interventions

Mefloquine (1)

Sponsors

Biogen (1)  ·  MacroGenics (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (2)  ·  Brazil (1)  ·  Germany (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

James M Schmitt, M.D. (1)

Results publications

PMID 23733308